Quality and equity in cardiovascular health in New Zealand: the need for agreed achievable standards of care, cohesive planning, and action.

New Zealand cardiovascular guidelines: best practice evidence-based guideline: the assessment and management of cardiovascular risk December 2003. Clin Biochem Rev (2007) 0.83

Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand. Can J Cardiol (2007) 0.81

Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities. N Z Med J (2004) 1.29

Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide audit. N Z Med J (2004) 1.24

A call to action on Maori cardiovascular health. N Z Med J (2004) 1.08

Cardiac rehabilitation services in New Zealand: access and utilisation. N Z Med J (2004) 1.06

Guidelines for pre-hospital administration of fibrinolytic therapy in New Zealand general practitioners. N Z Med J (2004) 0.89

Randomised trials in general practice--a New Zealand experience in recruitment. N Z Med J (2003) 2.23

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol (2005) 2.05

Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation (2004) 1.80

How low can it go? Projecting ischaemic heart disease mortality in New Zealand to 2015. N Z Med J (2006) 1.74

Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). Stroke (2009) 1.64

Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. J Am Coll Cardiol (2002) 1.55

Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand. Aust N Z J Public Health (2008) 1.52

Timing of thrombotic events in patients receiving 2 weeks of clopidogrel therapy post bare metal coronary artery stenting: a New Zealand retrospective study. N Z Med J (2007) 1.38

New Zealand's shocking diabetes rates can be reduced--9 urgently needed actions. N Z Med J (2011) 1.38

Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol (2003) 1.25

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail (2003) 1.08

Age-related changes in myocardial relaxation using three-dimensional tagged magnetic resonance imaging. J Cardiovasc Magn Reson (2003) 1.05

Aspirin for primary prevention: yes or no? J Prim Health Care (2010) 1.03

Cardiovascular aging and heart failure. Eur J Heart Fail (2003) 1.03

Review of 65 cases of infective endocarditis in Dunedin Public Hospital. N Z Med J (2004) 0.85

Heart health has an adverse future forecast in New Zealand: an alarm call to action across the continuum. N Z Med J (2006) 0.84

Streptokinase antibodies in patients presenting with acute coronary syndrome in three rural New Zealand populations. J Clin Pathol (2011) 0.79

The effect of an integrated care approach for heart failure on general practice. Fam Pract (2003) 0.78

Quantitative evaluation of regional endocardial visualisation with second harmonic imaging and contrast left ventricular opacification in heart failure patients. Eur J Echocardiogr (2005) 0.78

Use of evidence-based management for acute coronary syndrome. N Z Med J (2005) 0.77

Health equity: a prerequisite for social and economic progress. N Z Med J (2011) 0.77

Amino-terminal pro-C-type natriuretic peptide in heart failure. Hypertension (2003) 0.77

Prevention and reversal of left ventricular remodeling: summation. J Card Fail (2002) 0.76

Audit of a collaborative care model suggests patients with acute myocardial infarction are not disadvantaged by treatment in a rural hospital. N Z Med J (2002) 0.76

Rheumatic fever in New Zealand: from perennial failure to successful eradication. N Z Med J (2011) 0.75

Turning the tide of inequalities in heart health. N Z Med J (2006) 0.75

Depression and cardiovascular disease: a complex relationship. Eur Heart J (2003) 0.75

Rheumatic fever: from disease targeting to child-centredness. N Z Med J (2012) 0.75

Persistent rheumatic fever in New Zealand--a shameful indicator of child health. N Z Med J (2011) 0.75

Reducing health inequalities: a foremost priority. N Z Med J (2008) 0.75

Effect of tissue harmonic imaging and contrast upon between observer and test-retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure. Eur J Heart Fail (2004) 0.75

Evaluation of a rural primary-referred cardiac exercise tolerance test service. N Z Med J (2014) 0.75

Once-daily amoxicillin for Group A Streptococcal (GAS) sore throat as the other first-line option: a clarification of the NZ sore throat guidelines. N Z Med J (2011) 0.75

Inequities in health and the Marmot Symposia: time for a stocktake. N Z Med J (2011) 0.75

Bleeding events in patients receiving enoxaparin for the management of non-ST-elevation acute coronary syndrome (NSTEACS) at Dunedin Public Hospital, New Zealand. N Z Med J (2008) 0.75